GlassScriptPhysician profile
Syed Wasim
NPI 1992763809
$1,578.63
in general payments reported to CMS, 2019-2025
19 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2020: $86.00 · 2021: $127 · 2022: $287 · 2023: $205 · 2024: $194 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $622.72 | 2019-2025 | Freestyle Libre 3 |
| Astrazeneca Pharmaceuticals LP | $228.24 | 2019-2021 | |
| Pfizer INC. | $214.87 | 2019-2025 | |
| Glaxosmithkline, LLC. | $74.69 | 2021-2025 | Shingrix |
| Horizon Therapeutics Plc | $64.89 | 2020-2023 | Krystexxa |
| Merck Sharp & Dohme LLC | $56.59 | 2022-2023 | Belsomra, Steglatro |
| Inspire Medical Systems, INC. | $44.05 | 2024-2025 | Inspire |
| Stryker Corporation | $42.26 | 2025 | Conextions Tr Tendon Repair System-Implant Mechanism |
| Lilly USA, LLC | $41.61 | 2023 | Mounjaro |
| Janssen Pharmaceuticals, INC | $39.66 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $30.19 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.79 | 2023 | |
| Sanofi Pasteur INC. | $17.61 | 2019 | |
| Novartis Pharmaceuticals Corporation | $16.25 | 2022 | |
| Daiichi Sankyo INC. | $16.12 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $15.72 | 2025 | Cologuard Collection Kit |
| Inogen, INC. | $12.35 | 2022 | |
| Coloplast Corp | $11.54 | 2019 | |
| Sanofi-Aventis U.S. LLC | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Wasim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.